leslie-schrieber.jpg
Leslie Schrieber
Associate Professor
  • : 9463.1890    : (02) 9463.1793

Department of Rheumatology
royal north shore hospital, Sydney medical school
Australia

Education

Undergraduate record
High School

  • Leaving Certificate 1965:Maximum pass, Dux, Vaucluse Boys High
  • Aggregate mark 79th in state of NSW
  • Awarded Commonwealth Scholarship and University Bursary

Degrees and Diplomas

MB BS University of Sydney, 1972, Hons II
FRACP Fellow of the Royal Australasian College of Physicians, 1980
ECFMG Educational Council for Foreign Medical Graduates (ECFMG, USA) Certificate
(1972), Visa Qualifying Exam (VQE) 1979.
MD University of New South Wales 1982
Grad Cert.Clin.Ed University of New South Wales 2002

 

Biography

 

Research Interest

  • His major interests are inflammatory rheumatic diseases including rheumatoid arthritis, SLE (Lupus) and scleroderma
  • rheumatoid Arthritis, SLE and scleroderma

 

Professional Activities:

List Of Positions Held

Jan 1972 - Jan 1975 Resident Medical Officer, Royal Prince Alfred Hospital (RPAH).
Jan 1975 - Jan 1976 Medical Registrar, RPAH.
Jan 1976 - Jan 1977 Immunology Registrar, St. Vincent's Hospital, Sydney.
Jan 1977 - Jan 1978 Rheumatology Fellow, St. Vincent's Hospital.
Jan 1978 - Feb 1981 NH&MRC Postgraduate Research Scholar, Departments of Rheumatology and Immunology, St.Vincent's Hospital,Department of Medicine, University of NSW.
Feb 1981 -Feb 1982 Michael Mason Scholar, Division of Clinical Immunology, Kennedy Institute  of Rheumatology, Hammersmith, London.
Feb 1982 - Oct 1982 Maynard-Jenour Fellow, Division of Clinical Immunology, Kennedy Institute  of Rheumatology, Hammersmith, London, U.K.
Oct 1982 - Jan 1984 John E. Fogarty Visiting Research Associate, Connective Tissue Diseases Section, National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
Feb 1984 - Senior Lecturer in Medicine, Sydney University and Department of Rheumatology,  Royal North Shore Hospital,Visiting Rheumatologist, Royal North Shore Hospital, Visiting Rheumatologist, North Sydney Community Hospital. Consultant Rheumatologist, Greenwich Hospital.
Sep 1985 - July 1990 Director of Research, Sutton Rheumatism Research Laboratory, Royal North Shore Hospital.
July 1990 -Jan 1999 Director of Sutton Arthritis Research Laboratory, Royal North Shore  Hospital.
Jan 1991 - July 1991 Visiting Scientist, Lions Laboratory, Walter and Eliza Hall Institute for Medical Research, Melbourne, Victoria.
Sep 1991 - Oct 1992 Acting Head, Sydney University Department of Rheumatology, Royal North Shore Hospital.
Jan 1992 -Associate Professor of Medicine, Sydney University and Department of Rheumatology, Royal North Shore Hospital.
Sep 1993 - Sept 1996 Head, Sydney University Department of Rheumatology, Royal North Shore Hospital
Sep 1994 - Sept 1996, Academic Head, Discipline of Rheumatology, University of Sydney and Jan 1998 – 2008
2002 – 2008 Director, Center for Teaching Excellence in Musculoskeletal Disease, Institute of Bone and Joint Research, University of Sydney

Membership of Medical and Scientific Societies

  • American College of Rheumatology
  • Australian Medical Association
  • Australian Rheumatology Association
  • British Society for Rheumatology
  • Royal Australasian College of Physicians

Membership of National and State Committees and Organisations

Australian Rheumatology Association

Member of Research Sub-committee 1986 - 2000
Member of Council (NSW Branch) 1991-2001
Member of Federal Council 1998-2008
Member of Education and Training Committee 2001-2008
Chairman of Education and Training Committee 2002-2008

Other Membership

Programme Committee for XVI International Congress of  Rheumatology, Sydney 1985
Co-ordinating Co-chairman of the Connective Tissue Disease Section for the XVI International Congress of Rheumatology, Sydney 1985
Medical Advisory Panel of the Lupus Association of NSW (Inc) 1987 -
Assignor's Panel of The National Health and Medical Research Council 1989
Executive Committee, Australia and New Zealand Microcirculation Society 1991 -1996
Organising Committee, National Scientific Conference of the Australian Rheumatology Association, Sydney, May 1992 1991 -1992
Scientific Programme Committee, National Scientific Conference of the Australian Rheumatology Association, Sydney, May, 1992 1991 -1992
Organising Committee, 7th Biennial Scientific Conference of the Australian and New Zealand Microcirculation Society. Sydney, February, 1993 1992 -1993
Convenor, Organising Committee, Annual Scientific Meeting, NSW Branch of the Australian Rheumatology Association, October, 1993 1992 -1993
Local Organising Committee, International Scleroderma Conference                                  
Sydney, February, 1994. 		1992 -1994
Programme Subcommittee, International Scleroderma Conference, Sydney, February, 1994          1992 -1994
Co-ordinator, SLE and other inflammatory connective tissue diseases Section for APLAR (Asian Pacific League Against Rheumatism) Meeting, Melbourne, 1996   1993 - 1996
Assessment Subcommittee, Scientific Advisory Committee, Arthritis Foundation of Australia 1993 - 1996
President, Australia and New Zealand Microcirculation Society 1995 - 1997
President, Fellowship of Jewish Doctors of NSW Inc. 1996 - 1999
Scientific Programme Committee, National Scientific Conference of the Australian Rheumatology Association, Sydney, May 1998 1997 - 1998
President, Australasian Jewish Medical Federation (AJMF) 2000 - 2002
Chairman, Organising and Scientific Program Committee, 9th Biennial Conference of the Australasian Jewish Medical Federation and Alpha Omega, Coffs Harbour, January 2000 1998-
Member, Subcommittee on Auto-immune Disease, International  Conference on Allergy and Clinical Immunology, Sydney 2000, October 2000 1998-
Examiner, General Medicine Examination, Royal Australaian and New Zealand College of Psychiatrists, Sydney 1998-1999
Chairman, Scientific Program Committee, University of Sydney 30 Year Medical Graduates Reunion Conference, Hunter Valley, October 2002 2001- 2002
Chairman, Sponsorship Committee, University of Sydney 30 Year Medical Graduates Reunion Conference, Hunter Valley, October 2002 2001- 2002
Member, Medical Advisory Panel, The Scleroderma Association Of  NSW Inc 2002-
Member, Specialist Advisory Panel, Medical Observer 2003-2006
Chairman, Education and Training Committee of the Australian Rheumatology Association 2002-2008
Executive Member and Treasurer Australian Scleroderma Interest Group (ASIG) 2008-2014
Executive Member Australian Scleroderma Interest Group (ASIG) 2014-
Member, Organising Committee, University of Sydney 40 year Medical Graduates Reunion Conference, Canberra, October 2012. 2010-2012
Member, Organising Committee, University of Sydney 45 year Medical Graduates Reunion Conference, 2017 2012-
Member Medical and Scientific Advisory Panel Scleroderma Australia 2008-
Examiner for Clinical Examinations, Basic Physician Trainees, Royal Australasian College of Physicians, Sydney 2009-
Member, Steering Committee, AIM 2011 Conference Melbourne June 2011 2010-
Member, Academic Committee, Technion Society of Australia 2010-
Member Planning Committee for International Lupus Congress, Melbourne 2017 2012-

Membership of University Committees
Examinations Committee, Department of Medicine, University of Sydney 1986 –2000
Student Option Term Committee, University of Sydney 1989 – 1992
Co-ordinator of Vertical Stream Committee in Musculoskeletal Sciences, University of Sydney  1989 –1992
Co-ordinator of Professional Academic Support Scheme (PASS) at Royal North Shore Hospital 1989
Post-graduate Co-ordinator, Department of Medicine at  Royal North Shore Hospital 1990 –1996
Organising committee for Clinical Diagnosis – Medicine III, at Royal North Shore Hospital 1990 –1993
Organising Committee, Bridging Programme for AMC Exam Candidates, Postgraduate Committee in Medicine, University of Sydney 1990 –1992
Scientific Advisory Committee, Bone and Joint Research Foundation, University of Sydney 1990 –
Convenor, MCQ Bridging Course for Overseas Trained Doctors, Postgraduate Committee in Medicine, University of Sydney 1991 –1993
Continuing Medical Education Programme, Postgraduate Committee in Medicine, University of Sydney 1991 –1998
Discipline Head, Rheumatology, Department of Medicine, University of Sydney 1991 – 1993
Clinical Schools Working Party, Postgraduate Degree, University of Sydney          1992 –1995
Member, Clinical Academic Titles Committee, University of Sydney          1992
Convenor, “Arthritis in the Australian Community”, Centre for 1992
Continuing Education, University of Sydney, August, 1992.
Additional Member, Faculty Promotion Assessment Committee 1992
Interdepartmental Committee for Medical Communication 1993 –1995
Co-ordinator, Planning Team for Musculoskeletal Sciences and Skin,University of Sydney          1993 –1996
Chairman, Research Committee, Department of Medicine,University of Sydney          1993 – 1994
Member, Research Committee, Department of Medicine, University of Sydney      1994-1996
Post-graduate Committee in Medicine, University of Sydney 1994-1996
Post-graduate Co-ordinator, Department of Medicine, Northern Clinical School 1994-1998
Board of Postgraduate Studies, University of Sydney 1994-1998
Patient-Doctor Planning Team, Graduate Medical Program 1994 –1996
Block Chair, Musculoskeletal Sciences, Graduate Medical Program,University of Sydney 1995
Deputy Director, Bone and Joint Research Foundation, University of Sydney 1995 –2000
Member, Basic and Clinical Sciences Theme Committee, Graduate Medical Program, University of Sydney 1995 –1998
Chairman, Problem Based Learning Subcommittee, Northern Clinical School         1996 –1998
Member, Clinical Skills Laboratory Working Party, Northern Clinical School          1996 –1998
Member, Skills Laboratory for the Graduate Medical Program, University of  Sydney 1996 –1998
Member, Review of Examination Results Committee for the Graduate Medical Program. 1997 –1998
Section Co-ordinator, Rheumatology, Department of Medicine, University of Sydney.      1998 –2008
Chairman, Assessment Committee, Musculoskeletal Sciences, Graduate1996-1999 Medical Program, University of Sydney  
Member, Working Party for Formative Assessment Paper, 1999-2001 Block 1, Graduate Medical Program, University of Sydney  
Secretary/ Treasurer, Institute of Bone and Joint Research, Univesrity of Sydney 1999-2007
Secretary/ Treasurer, Bone and Joint Research Foundation, University of Sydney 1999-2007
Member, Academic Forum, Unversity of Sydney  2001-2003
Member, Postgraduate Committee Forum, Postgraduate Committee in Medicine University of Sydney 2002-2005
Member, Faculty Education Committee 2003-2005 Chairman, Faculty of Medicine Curriculum Review, Working Party on Clinical Teaching on Ambulant and Standardised Patients  2007
Member, Faculty of Medicine Curriculum Review, Working Party on Interprofessional Learning 2007
Faculty Clinical Skills Co-ordinator, University of Sydney 2008
Member,  Sydney Medical School Doctors Health Initiative 2009
Deputy Head Department of Medicine, Northern Clinical School  2009-
Member Human Research Committee, University of Sydney  2013-
Stage 3 Co-ordinator Northern Clinical School  2014

 

Publications

Publications and work in progress

Book chapters and monographs

  1. Schrieber L.   Factors influencing immune complex localisation.  MD Thesis, University of New South Wales, 1981.
  2. Schrieber L.  Pathogenesis of systemic lupus erythematosus in `Rheumatology - 85'.  Edit by P.M. Brooks and J.R. York, Elsevier Scientific Publications, Excerpta Medica, Amsterdam, pp131-149, 1985.
  3. Schrieber L.  Immunomodulators in: Symposium on Anti-rheumatic drugs; Basis for variability in response.  Agents and Actions (Supplement) edited by Brooks P.M., Day R.D., Williams K., Graham G., Birkhauser Verlay, Basel. 254-264, 1988.
  4. Arnold M., Schrieber L. and Brooks P.M.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.  Drugs 36:340- 363, 1988.
  5. Brooks, P., Schrieber L. and Nash P.  The Rheumatological System in “Clinical Examination”.  Edited by N.J. Talley and S. O’Connor, Williams & Wilkins and Associates, Sydney, Chapter 8, 206-242, 1988.
  6. Schrieber L.  Arthritis in  "Disease and Society" edit by R. Dirks, Australian Academy of Science, Canberra, 2-33 to 2-34, 1989.
  7. Schwarzer A.C. and Schrieber L.  Rheumatic manifestations of neoplasia in "Current Opinion in Rheumatology"  Edited by D.J. McCarty, Current Science, Philadelphia, 545-550, 1989.
  8. Schwarzer A.C. and Schrieber L.   Rheumatic manifestations of neoplasia in "Current Opinion in Rheumatology" Edited by D.J. MCarty, Current Science, Philadelphia, 3, 145-154, 1991.
  9. Schrieber L.   Rheumatoid Arthritis: The Endothelium in Rheumatoid Arthritis in "Rheumatology" edited by Klippel J.H. and Dieppe P, Mosby-Yearbook Europe Limited,  London, 10.1-106, 1994.
  10. Arnold M.H and Schrieber L.  Flare of Polymyalgia Rheumatica with Corticosteroid Taper  in Rheumatology edited by Klippel JH and Dieppe PA., Mosby-Yearbook Europe Limited, 18.3-18.4, 1994.
  11. Arnold M.H. and Schrieber L. Flare of Polymalgia Rheumatica with Corticosteroid Taper in Practical Rheumatology, Klippel J.H. and Dieppe P.A. Mosby, 411-412, 1995.
  12. Manolios N. and Schrieber L.  Systemic lupus erythematosus.  Oxford Textbook of Clinical Immunology, edited by J. Bradley and J. McCluskey ,329-345, 1997.
  13. Schrieber L and Jackson C.  Rheumatoid Arthritis: Angiogenesis in “Rheumatology” 2nd Edition, edited by Klippel JH and Dieppe P, Mosby-Yearbook Europe Limited, London ,12.1-12.4,1997.
  14. Schrieber L Rheumatoid Arthritis and the Hand. In “ Systems of The Body: Musculoskeletal System” edited by Sambrook P Schrieber L Ellis A and Taylor, Churchill Livingstone, Edinburgh,1-20,2001
  15. Jackson CJ and Schrieber L Rheumatoid Arthritis: Angiogenesis in”Rheumatology” 3rd Edition, edited by Hochberg MC et al, Mosby, London, 851-854, 2003.
  16. Schrieber L and Colley M. Patient Education: Bailliere’s Clinical Rheumatology edited by Sambrook PN and March LM, Elsevier, 465-476;18:2004
  17. Schrieber L (contributing Specialist Consultant) Mosby’s Dictionary of Medicine, Nursing & Health Professions edited by Harris P, Nagy S and Vardaxis N, Elsevier, 2006
  18. Schrieber L (contributing Specialist Consultant) Mosby’s Dictionary of Medicine, Nursing & Health Professions 2nd Edition edited by Harris P, Nagy S and Vardaxis N, Elsevier, 2009.
  19. Schrieber L Rheumatoid Arthritis and the Hand. In “Systems of The Body: Musculoskeletal System” edited by Sambrook P Schrieber L Taylor T and Ellis A, Churchill Livingstone, Edinburgh 1-18, 2010.
  20. Schrieber L (contributing Specialist Consultant) Mosby’s Dictionary of Medicine, Nursing & Health Professions 3nd Edition edited by Harris P, Nagy S and Vardaxis N, Elsevier, 2014.

Articles In Peer Reviewed Journals

  1. Schrieber L. and Penny R.  Tissue C3b receptors. Clin. Exp.  Immunol. 38, 316-322, 1979.
  2. Schrieber L. and Penny R.  Receptors on human synovial cells.  Arthritis Rheum. 23, 1333, 1980.
  3. Schrieber L. and Penny R.  Tissue distribution of IgG Fc receptors. Clin. Exp. Immunol. 47, 535-540, 1982.
  4. Wakefield D., Schrieber L and Penny R.  Immunological factors in uveitis.  Med. J. Aus. 1,229-231, 1982.
  5. Venables P.J.W., Charles P.J., Buchanan, R.R.C., Tung Y.I., Mumford P.A., Schrieber L., Room G.R.W.  and Maini R.N.  Quantitation and detection of isotopes of anti-SS-B antibodies by Farr and ELISA assays using affinity purified antigens: an approach to the investigation of Sjogren's Syndrome and systemic lupus erythematosus.  Arthritis Rheum. 26, 146-153, 1983.
  6. Schrieber L., Erhardt C.C., Melsom R.D., Venables P.J.W., McCarthy D., Mumford P., Horsfall A.C., and Maini R.N.  In vivo fate of 125 I SS-B (La) injected into mice. Immunology.  48, 771-778, 1983.
  7. Schrieber  L., Melsom R.D., Venables P.J.W., and Maini R.N.  Organ uptake and catabolic studies of 125 I SS-B (La) injected into mice. Clin. Immunol. Immunopathol. 31, 24-32 1984.
  8. Schrieber L., Melsom R.D., Venables P.J.W., McCarthy D., and Maini R.N.  Specific autoantibody slows the rapid plasma clearance of 125 I SS-B (La) in mice.  Clin. Exp. Immunol.  56, 621-627. 1984.
  9. Schrieber L. Effects of anti-rheumatic drugs in "Evolving concepts of the pathogenesis and therapy of rheumatoid arthritis"  moderated by Decker J.L.  Ann. Intern. Med. 101, 810-824, 1984.
  10. Schrieber L. and Penny R.  Factors influencing immune complex localisation.  A review.  Rheumatol. Internat. 4,95-110, 1984.
  11. Schrieber L. and Maini R.N.  Circulating immune complexes in connective tissue diseases.  Neth. J. Med. 27,327-339, 1984.
  12. Schrieber L., Mullins W.M. and Plotz P.H. Failure of methotrexate and methylprednisolone to alter the clearance of model immune complexes. J. Rheum. 12, 1044-1047, 1985.
  13. Schrieber L., Steinberg A.D., Rosenberg Y.J., Csehi E.E., Paull S.A. and Santoro T.J.  Aberrant lymphocyte trafficking in murine systemic lupus erythematosus.   Rheumatol. Internat.  6, 215-219, 1986.
  14. Melsom R.D., Horsfall A.C., Schrieber L., Charles P. and Maini R.N.  Anti- Clq affinity isolated circulating immune complexes correlate with extra- articular rheumatoid disease.  Rheumatol.  Internat.  6, 227-231, 1986.
  15. Schrieber L. and Edmonds J.P.  Pathogenesis of systemic lupus erythematosus: Clin. Exp. Rheum. 4,157-160, 1986.
  16. Manolios N. and Schrieber L.  Current concepts in the aetiopathogenesis and treatment of systemic lupus erythematosus (SLE).  Aust. NZ J. Med. 16,729-743, 1986.
  17. Schrieber L., Manolios N, To S.S.T., Geczy C.L. and Breit S.N. Lymphocyte trafficking in inflammatory rheumatic disease: A role for receptor mediated homing.  J. Rheum. 14, 194-196, 1987.
  18. Schrieber L.  Microvascular changes in rheumatoid arthritis in "Progress in microcirculation research" edited by Garlick D.G.  and Perry M.A., Centre for Continuing Medical Education, UNSW, 13, 1987.
  19. Mullins W.W., Plotz P.H. and Schrieber L.  Soluble immune complexes in lupus mice: clearance from blood and estimation of formation rates.  Clin. Immunol. Immunopathol.  42, 375-385, 1987.
  20. Nash P., Schrieber L. and Webb J.  Interstitial lung disease as the presentation of anti- Jo1 positive polymyositis.  Clin. Rheum. 6, 282-286, 1987.
  21. Garbett P.K., Jackson C.J., Brooks P.M. and Schrieber L. Vessel-like sprouts may develop from fibroblasts in vitro. Cell. Biol. Internat. Reports 11,835, 1987.
  22. Cohen M.G., Pollard K.M. and Schrieber L.  Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice.  Clin. Exp.  Immunol. 72, 50-54, 1988.0.
  23. Schrieber L., McCredie M., Tugwell P. and Brooks P.M.  An evaluation of the role of laboratory investigations in establishing a diagnosis of central nervous system (CNS) lupus.  Brit. J. Rheum. 27, 138-142, 1988.
  24. Arnold M. and Schrieber L.  Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies.  Clin. Rheum. 7,406-410, 1988.
  25. Manolios N., Geczy C. and Schrieber L.  High endothelial venule morphology and function are inducible in germ-free mice: A possible role for interferon-gamma.  Cell Immunol. 117,136-151, 1988.
  26. Manolios N., Geczy C, and Schrieber L.  Anti-Ia monoclonal antibody (10- 2.16) inhibits lymphocyte-high endothelial venule (HEV) interaction: Cell. Immunol. 117,152-164, 1988.
  27. Schrieber L., Manolios N., Cohen M.G., Paull S.A., Guiffre A.K. and Hopper K.E.  Lymphocyte migration patterns in autoimmune MRL-lpr/lpr mice: relationship to age, disease manifestations and lymphocyte homing receptor expression.  Autoimmunity 3,5- 15, 1989.
  28. Manolios N., Schrieber L., Nelson M., Geczy C.L.  Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/l, MRL/n) mice.  Clin. Exp. Immunol. 76,301-306, 1989.
  29. Jackson C.J., Garbett P.K., Marks R.M., Chapman G., Sonnabend D.H., Potter S.R., Brooks P.M. and Schrieber L.  Isolation and propagation of endothelial cells derived from rheumatoid synovial microvasculature.  Ann. Rheum. Dis. 48,733-736, 1989.
  30. Arnold M.H., Janssen B., Schrieber L. and Brooks P.M.  Prospective pilot study of intravenous pulse  cyclophosphamide in refractory rheumatoid arthritis.  Arthritis Rheum. 32,933-934, 1989.
  31. Shenstone B., Schrieber L., Yong J.L.C. and Charlesworth J.A.  Clinicopathological  conference: Migratory polyarthralgia and haemoptysis.  Med. J. Aust. 150. 387-390, 1989.
  32. Field M., Melsom R.D., Brennan F.M., Williams D.G., Mumford P.A., Schrieber L. and Maini R.N.  Rapid clearance of the Sm lupus antigen: a possible mechanism of autoimmunity perpetuation.  Clin. Exp. Immunol. 78,460-464, 1989.
  33. Bauman A., Barnes C., Schrieber L., Dunsmore J. and Brooks P.M.  The unmet needs of patients with SLE: planning for patient education.  Patient Education and Counselling.  14,235-242, 1989.
  34. Wang Y., Schrieber L, Cohen M.G., Furphy L., Webb J., Chivers T, and Pollard K.M.  Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients      Rheumatol Internat. 10, 75-80, 1990.
  35. McCredie M., Celermajer J., Sholler G., Kelly D., Chivers T., Wang Y. and Schrieber L.  A case-control study of congenital heart block: association with maternal antibodies to Ro(SS-A) and La(SS-B).  Brit. J. Rheum. 29,10- 14,1990.
  36. To S.S.T. and Schrieber L.  The effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cells.  Clin. Exp. Immunol. 81, 160-165, 1990.
  37. Jackson C.J., Garbett P.K., Nissen B. and Schrieber L.  Binding of human endothelium to Ulex Europaeus I coated dynabeads: application to the isolation of microvascular endothelium.  J. Cell. Sci. 96, 257-262, 1990. 
  38. Manolios N., Geczy C. and Schrieber L.  Aberrant lymphocyte migration patterns in systemic lupus erythematosus (MRL/l, MRL/n) mice are independent of the microenvironment.  Autoimmunity, 7, 139-148, 1990.
  39. Tymms K.E., Beller E.M., Webb J., Schrieber L. and Buchanan W.W.   Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.   Clin. Rheumatol. 9, 523-9, 1990.
  40. Schwarzer A.C., Arnold M.H., Kelly D., Jones M., Beller E., McNaught P.J., Schrieber L. and Brooks P.M.  The  cycling of combination anti-rheumatic drug therapy in  rheumatoid arthritis.  Brit. J. Rheumatol, 29, 445-450, 1990 .
  41. Schwarzer A.C., Fryer J, Preston S.J., Schrieber L. and McNaught P.  Metastatic adenosquamous carcinoma presenting as an acute ankle  monoarthritis, with a review of the literature.  J. Orthopaedic Rheumatol. 3, 175-185, 1990.  
  42. Manolios N., Bakiera B., Geczy C.L. and Schrieber L.  Aracadonic acid metabolites in normal and autoimmune mice do not influence lymphocyte -HEV interactions.  Immunol. Cell. Biol. 69, 39-46, 1990.
  43. Gallery E.D.M., Rowe J., Schrieber L. and Jackson C.J.  Isolation and purification of microvascular endothelium from late pregnancy decidual endothelium.  Am. J. Obstet. Gynaecol. 165, 191-196, 1991.
  44. Manolios N., Geczy C.L. and Schrieber L.   Lymphocyte migration in health and inflammatory rheumatic disease.   Semin. Arthr. Rheum. 20, 339-352, 1991.
  45. Tymms K.E., Beller E.M., Schrieber L., Webb J. and Buchanan W.W.  A statistical study of matching patients with dermatomyositis and polymyositis.  Inflammo-pharmacology.  1, 195-200, 1992.
  46. To S.S.T., Magoulas T, Nicholson E and Schrieber L.   Identification of a human endothelial cell activation antigen that is co-expressed by germinal follicle centre B lymphocytes.   Immunology.  76, 616-624, 1992.
  47. Jackson C.J, Jenkins K. and Schrieber L.   Possible mechanisms of type I collagen- induced vascular tube formation in Angiogenesis.   Key Principles - Science-Technology-Medicine edited by Steiner R, Weisz PB and Langer  R, Birkhause Verlag, Basle, Switzerland, 198-204, 1992.    
  48. Nethery A., Giles I., Jenkins K., Jackson J., Brooks P., Burkhardt D., Ghosh P, Whitelock J., O'Grady R.L., Welgus H.G. and Schrieber L.   The chondroprotective drugs arteparon and sodium pentosan polysulphate, increase collagenase activity and inhibit stromelysin activity in vitro.   Biochem. Pharmacol. 44,1549-1553, 1992.
  49. The Australian Multicentre Clinical Trial Group.   Sulfasalazine in early rheumatoid arthritis.  J. Rheumatol. 19, 1672-1677, 1992.
  50. Lee M.L, To S.S.T., Cooper A., Jones M. and Schrieber L.   Augmented lymphocyte binding to cultured endothelium in psoriasis.   Clin. Exp. Immunol. 91; 346-350, 1993.
  51. Lee M.L., To S.S.T., Nicholson E. and Schrieber L.  Endothelial cell adhesion molecules in psoriasis.  The Australasian Journal of Dermatology 35;65-70, 1994.
  52. *Newman P., To S.S.T., Robinson B.G., Hyland V.J. and Schrieber L.  Effect of gold sodium thiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules.  J. Clin. Invest 94; 1864-1871, 1994.
  53. Jackson C.J., Knop A., Giles I., Jenkins K. and Schrieber L.  VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation.  Cell Biol. Internat. 18;859-867, 1994.
  54. Jackson C.J., Giles I, Knop A., Nethery A. and Schrieber L.  Heparin, pentosan polysulphate or dextran sulphate are required for collagen-induced vascular tube formation.  Exp. Cell Res. 215;294-302, 1994.
  55. Lowe P.M., Lee M.L., To S.S.T., Jackson C.J., Cooper A.J. and Schrieber L.  The endothelium in psoriasis.  Brit. J. Dermatol, 132;497-505, 1995.
  56. To S.S.T. Newman P.M. Hyland V.J., Robinson B.G. and Schrieber L.  Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro.  Arthritis Rheum 39,467-477, 1996.
  57. Shen J, ToSST, Schrieber L. and King N.J.C. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines.  J. Virol, 71, 9323-9332, 1997.
  58. Hendry G, Schrieber L and Bryce D. Patients as teachers -partners in arthritis education. Medical Education 33, 674-677, 1999
  59. Hunter D, Schrieber L, Hendry G, Laurent R, March L and Sambrook P. Assessment of rheumatological education of final year medical undergraduate students. APLAR Journal 3,237-241, 2000
  60. Schrieber L, Hendry GD and Hunter D. Musculoskeletal examination teaching in rheumatoid   JRheumatol 27,1531-2, 2000
  61. Champion BL, Choy F, Schrieber L, Roche J and Rowe DB. Isolated fascicular oculomotor nerve palsy as the initial presentation of the antiphospholipid sydrome. J Clin Neuroscience 9,691-694, 2002
  62. Denton F, Sharpe L and Schrieber L. PRISM: Enmeshment of illness and self-schema. Psychotherapy and Psychosomatics 73,57-63, 2004.
  63. Sharpe L, Denton FJ and Schrieber L. Validity of the Disease Repercussion Profile in patients with systemic lupus erythematosus. Lupus 13,428-435,2004.
  64. Denton FJ, Sharpe L and Schrieber L. Cognitive bias in systemic lupus erythematosous. European Journal of Pain 9,5-14,2005.
  65. Englert H, Katelaris C, McGill N, Schrieber L and Moore J. “Grape-sultana”sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma. Int Med J 35; 436-437,2005.
  66. Monaghan SM, Sharpe L, Denton F, Levy J, Schrieber L and Sensky T. Relationship between appearance and psychological distress in rheumatic diseases. Arthritis Care & Research 57, 303-309, 2007.
  67. Englert H, Kirkham S,Moore J, Poon TS, Katelaris C, McGill N, Schrieber L and Manolios N. Autologous stem cell transplantation in diffuse scleroderma: impact on hand structure and function. Int Med J 38,692-696, 2008:
  68. Sharpe L, Dear BF and Schrieber L. Attentional biases in chronic pain associated with rheumatoid arthritis: hypervigilance or difficulties disengaging? Journal of Pain 10,329-335,2009
  69. O’Neill SG, Giles I, Lambrianides A, Manson J, D’Cruz D, Schrieber L, March LM, Latchman, DS Isenberg DA and Rahman A. Antibodies to apolipopotein A-1, high density lipoprotein and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis & Rheum 62,845-854, 2010
  70. Morris BJ, Wodak AD, Mindel A, Schrieber L, Duggan KA, Dilley A, Willcourt RJ, Lowy M, Cooper DA, Lumbers ER, Russell CT and Leeder SR. Infant male circumcision: An evidence-based policy statement. Open Journal of Preventive Medicine 2,79-92,2012
  71. Sharpe L and Schrieber L. A Blind Randomized Controlled Trial of Cognitive versus Behavioral versus Cognitive-Behavioral Therapy for Patients with Rheumatoid Arthritis. Psychotherapy and Psychosomatics, 81, 145-152,2012
  72. Morris BJ, Wodak AD, Mindel A, Schrieber L, Duggan KA, Dilley A, Willcourt RJ, Lowy M and Cooper DA.The 2010 Royal Austrasian College of Physicians policy statement “ Circumcision of infant males” is not evidence based Int Med J 42,822-827,2012
  73. Siow SF, Yu S and Schrieber L Meningococcal septic arthritis: an uxexpected cause with public health implications. International Journal of Reumatic Diseases Oct 2014( in press)

Invited Articles and Reviews

  1. Manolios N. and Schrieber L.  Polymyalgia Rheumatica.  Australian Family Physician.  15,1298-1301, 1986.
  2. Garbett P.K., Jackson C.J., Brooks P.M. and Schrieber L.  Sprout formation and luminal development in vitro.  in Microcirculation - an update, Vol. 2, editor M. Tsuchiya et al, Elsevier Scientific Publ. Amsterdam, 805-806, 1987.
  3. Nash P. and Schrieber L.  The use and interpretation of investigations in rheumatic disorders.  SEAPAL Bulletin.  5,70-73, 1987.
  4. Arnold M. and Schrieber L.  New treatments in rheumatoid arthritis.  Modern Medicine of Australia.  31,14-25, 1988.
  5. Garbett P.K., Nissen B., Jackson C.J., Brooks P.M. and Schrieber L.   Examination of the organisation of endothelial cells into vascular tubes in vitro.   The influence of extracellular matrix.  in "Progress in Microcirculation Research"  edited by Garlick DG and Perry MA, Centre for Continuing Medical Education, UNSW, 3, 1989.
  6. Arnold M.H. and Schrieber L.  Investigations in rheumatology.  Modern Medicine.  32,76-87, 1989.
  7. Schrieber L.  Reaction: The connective tissue connection.  Current Therapeutics.  30,77-79, 1989.
  8. Schrieber L., Jackson C.J. and Garbett P.K.  Angiogenesis in rheumatoid arthritis.  Bulletin of the Postgraduate Committee in Medicine, University of Sydney.  46, 37-44, 1990.
  9. Preston S. and Schrieber L.  Polymyalgia rheumatica and giant cell arteritis.  MIMS Disease Index. 432-457, 1991/1992.
  10. To S.S.T., Magoulas T., Nicholson E. and Schrieber L.   Co-expression of an antigen  on activated human endothelial cells and germinal follicle centre B lymphocytes in "Progress in Microcirculation Research" edited by Garlick D.G. and Perry M.A., Centre for Continuing Medical Education, UNSW, 5-6, 1991.
  11. Jackson C.J., Gallery E.D.M., Schrieber L.   Human endothelial cells bind to, and can be purified by Ulex Europaeus I coated Dynabeads in "Magnetic separation techniques applied to cellular and molecular biology" edited by J.T. Kemshead, Bristol, UK, Wendsmith's Conference Publications, 63-73. 1991.
  12. Arnold M.H., Sonnabend D.H. and Schrieber L.   Current management of rheumatoid arthritis.   Modern Medicine of Australia, 35, 30-43, 1992.
  13. Brooks P.M., Edmonds J.P., March L. and Schrieber L.   The core curriculum - an Australian experience.   Proceedings of the APLAR Conference, Bali, September, 1992.  Editors Nasution AR, Darmawan J and Isbagio H.   Churchill Livingstone.  427-429, 1992.
  14. Jackson CJ., Giles I. and Schrieber L.  The study of angiogenesis using cultured microvascular endothelial cells in "Progress in Microcirculation Research" edited by Garlick DG and Perry MA., Centre for Continuing Medical Education, UNSW 17-19, 1993.
  15. Newman P, To SST and Schrieber L.  Gold sodium thiomalate inhibits vascular cell adhesion molecule 1 expression on endothelial cells in "Progress in Microcirculation Research" edited by Garlick DG and Perry MA, Centre  for Continuing Medical Education, UNSW 52-53, 1993
  16. Lowe P., Jackson C.J., Giles I., LeGuay J. and Schrieber L.   Psoriasis and the endothelium in "Progress in Microcirculation Research" edited by Garlick D.G. and Perry M.A., Centre for Continuing Medical Education, UNSW  68-70, 1993.
  17. Arnold MH and Schrieber L.   Vasculitis in the elderly.   Modern Medicine of Australia, 36, 24-34, 1993.
  18. Brown MA and Schrieber L.   Medications used in the management of lupus and drug-induced lupus.   Australian Pharmacist, 12, 561-566, 1993.
  19. Brown MA and Schrieber L.   Systemic lupus erythematosus.  Part I: An overview of diagnosis and clinical manifestations.  General Practitioner CME, 1, 259-263, 1993.
  20. Brown MA and Schrieber L.   Systemic lupus erythematosus.  Part II:  autoantibodies, drug-induced lupus, and new treatments.  General Practitioner CME, 1, 279-283, 1993.
  21. Schrieber L, Newman P, Robinson BG, Hyland V and To SST.  "The role of endothelial adhesion molecules in inflammation" in "Progress of Microcirculation Research in Asia,” Permagon, Elsevier Science, 271-274, 1994.
  22. Arnold MH and Schrieber L.  Management of rheumatoid arthritis.  General Practitioner CME 2, 51-56, 1994.
  23. Brown M.A. and Schrieber L.  Systemic lupus erythematosus.  Patient Management New Zealand, 23, 79-85, 1994.
  24. Schrieber L, Newman P, Robinson BG, Hyland V and To SST.  “The endothelium in rheumatoid arthritis” in “Progress in Microcirculation Research” edited by Garlick DG and Perry MA.  Centre for Continuing Medical Education, UNSW, 61-63, 1995.
  25. Preston S and Schrieber L.  Polymyalgia rheumatica and giant cell arteritis.  MIMS Disease Index, 2nd edition, 420-422, 1996.
  26. Brown M.A. and Schrieber L.  Systemic lupus erythematosus.  Current Therapeutics. 37,53-60, 1996.
  27. Bannister M.J., Jackson C.J., Nguyen Q.M., Cooper A.J. and Schrieber L.  “Isolation and characterisation of microvascular endothelium derived from human psoriatic plaques” in “Progress in Microcirculation Research” edited by Rogers P.A.W., Cooke B.M., Andrews F.J., and Knight K.R., Monash Print Services, Monash University, 117-118, 1997.
  28. Brown M.A. and Schrieber L. Systemic Lupus erythematosus, Therapeutics, 2, 23-28, 1997.
  29. Dorai-Raj A. and Schrieber L.  The role of corticosteroids in rheumatology.  Australian Prescriber 21, 11-14, 1998.
  30. Bagga H and Schrieber L. Scleroderma. Modern Medicine October 2001:50-58
  31. Lim A and Schrieber L Management of Systemic Sclerosis Israeli Medical Association Journal 4 (Suppl) 953-957,2002
  32. O”Neill SG and Schrieber L: Systemic Lupus Erythematosus: Medicine Australia 5, 28-38,2004
  33. O’Neill SG and Schrieber L. Immunotherapy of systemic lupus erythematosus. Autoimmunity Reviews 395-402;4: 2005.
  34. Schrieber L Lupus: No longer an acute fatal disease, but a chronic living disease. Pulse News Virtual Medical Centre January 2006
  35. O”Neill SG and Schrieber L: Systemic Lupus Erythematosus: Medicine Australia 2009 (in press)
  36. Richards B and Schrieber L  Changing face of Scleroderma Pulse News Virtual Medical Centre 2010
  37. Sinnathurai R and Schrieber L Raynauds phenomenon in systemic sclerosis Int Med J 2013 43;476-483
  38. Chessman D and Schrieber L Systemic Lupus Erythematosus: An Improving Prognosis Medicine Today Sep 2014

Abstracts

  1. Schrieber L. and Champion G.D. Yttrium  90 intra-articular injections in rheumatoid arthritis.  Aus. N.Z.J. Med., Suppl. 1, 180, 1978.
  2. Schrieber L. and Penny R.  Glomerular C3b receptors - a quantitative approach.  Presented at Australian Society for Medical Research, Cowes, Victoria, December, 1978.
  3. Schrieber L. and Penny R.  Tissue distribution of C3b receptors. Aus. N.Z.J. Med., 10, 271, 1980.
  4. Schrieber L. and Penny R.  Tissue distribution of C3b receptors. Presented at 4th SEAPAL Meeting, Manilla, Philippines, January, 1980.
  5. Schrieber L. and Penny R.  Tissue distribution of IgG Fc receptors.  Aus. N.Z.J. Med., 11, 717, 1981.
  6. Schrieber L. and Penny R.  Tissue distribution of IgG Fc receptors.  Presented at IV International Congress of Rheumatology, Paris, June, 1981.
  7. Schrieber L., Erhardt C.C., Melsom R.D., Venables P.J.W., McCarthy D., Mumford P., Horsfall A.C. and Maini R.N.  In vivo fate of  125I SS-B (La) injected into mice.  Clin. Rheum. 1, 1982.
  8. Horsfall A.C., Venables P.J.W., Mumford P.A., Schrieber L. and Maini R.N.  Binding of antinuclear antibodies to EBV transformed lymphoblastoid cell lines.  Clin. Rheum. 1, 1982.
  9. Schrieber L., Erhardt C.C., Melsom R.D., Venables P.J.W., McCarthy D.A., Mumford P., Horsfall A.C. and Maini R.N.  In vivo fate of  125I SS-B (La) injected into mice.  Presented at Scientific Meeting of the British Society for Immunology, March, 1982.
  10. Melsom R.D., Schrieber L., Venables P.J.W., McCarthy D.A. and Maini R.N. 125I SS-B (La) - Tissue uptake, catabolism and influence of IgG anti-SS-B on its in vivo behaviour in mice. Presented at Annual General Meeting of the Heberden Society, London, November, 1982.
  11. Field  M., Schrieber L., Melsom R.D., Venables P.J.W., McCarthy D.A. and Maini R.N.  The in vivo fate of soluble cellular antigens in a murine model.  Presented at Second Annual Scientific Workshop of EULAR, Mainz, W. Germany, February, 1983.
  12. Mullins W.M., Plotz P.H. and Schrieber L.  Defective  clearance of model immune complexes in MRL-1pr/1pr (MRL/1)  mice compared with BXSB, C3H/HEN and BALB/C strains.   Arthritis Rheum, 27, S53, 1984.
  13. Schrieber L., Steinberg A.D., Rosenberg Y.J., Csehi E. and Santoro T.J.  Aberrant lymphocyte trafficking in systemic lupus erythematosus (SLE) mice.  Presented at 14th Annual Meeting of Australian Society for Immunology, Perth, December 1984.
  14. Schrieber  L, Mullins WW. and Plotz P.H.  Failure of methotrexate (MTX) and methylprednisolone (MP) to alter the clearance of model immune complexes.  Presented at 14th Annual  Meeting of Australian Society for Immunology, Perth, December 1984.
  15. Mullins WW, Schrieber L and Plotz PH.  Clearance of antigen and immune complexes from the circulation.  Presented at "Meeting on Autoimmunity in Rheumatic Diseases", Kennedy Institute of Rheumatology, London, December 1984.
  16. Schrieber L., Mullins W.W. and Plotz P.H.  Failure of methotrexate (MTX) and methylprednisolone (MP) to alter the clearance of model immune complexes.  Aust. N.Z.J. Med., 15, 184, 1985.
  17. Mullins W.W., Plotz P.H. and Schrieber L.  Defective clearance of model immune complexes in MRL-1pr/1pr (MRL/1) mice compared with BXSB,  C3H/HEN and BALB/C strains.  Aust. N.Z.J. Med., 15, 184, 1985.
  18. Schrieber L., Steinberg A.D., Rosenberg Y.J., Csehi E. and Santoro T.J.  Aberrant lymphocyte trafficking in systemic lupus erythematosus (SLE) mice.  Aust. N.Z.J. Med., 15, 178, 1985. 
  19. Schrieber L., Steinberg A.D., Rosenberg Y.J., Csehi E. and Santoro T.J.  Aberrant lymphocyte trafficking in systemic lupus erythematosus (SLE).  Presented at XVI International Congress of Rheumatology, Sydney, May 1985.
  20. Paull S.A. and Schrieber L.  Age dependent lymphocyte trafficking patterns in MRL- 1pr/1pr mice.  Presented at 1st combined meeting of New Zealand and Australian Societies for Immunology, Queenstown, N.Z., December, 1985.
  21. Schrieber L. and Paull S.A.  Tissue distribution of 51Cr-labelled lymphocytes in autoimmune mice.   Aust. NZ J Med., 16, 171, 1986.
  22. Schrieber L., Paull S.A., Guiffre A.K., Cohen M.G. and Hopper K.E.  Relationship of lymphocyte trafficking profiles to disease expression in MRL-lpr/lpr mice.  Presented at 1st International Conference on SLE, Calgary, Alberta, Canada, June, 1986.
  23. Schrieber L. and Paull S.A.  Abnormal lymphocyte trafficking in autoimmune mice.   Presented at 6th International Congress of Immunology, Toronto, Canada, July, 1986.
  24. Cohen M.G., Pollard K.M., Webb J. and Schrieber L.  Antihistone antibodies in MRL- +/+ mice are age and sex dependent.  Aust. NZ.  J. Med. 17, 154, 1987 (Supplement).
  25. Manolios  N., Geczy C. and Schrieber L.  Augmented lymphocyte-high endothelial venule (HEV) binding in auto-immune mice.  Aust. NZ.  J. Med. 17, 172, 1987 (Supplement).
  26. Schrieber L., Guiffre A.K. and Manolios N.  Aberrant lymphocyte trafficking profiles in systemic lupus erythematosus (SLE) mice are micro-environment independent.  Presented at Annual Scientific Meeting of Australian Society for Immunology, Newcastle, December, 1986.
  27. Furphy L., Cohen M.G., Schrieber L and Pollard K.M.  Monoclonal antibodies to nuclear antigens (ANA) from auto-immune mice.  Presented at Annual Scientific Meeting of Australian Society for Immunology, Newcastle, December, 1986.
  28. Manolios N., Al-Salami M., Geczy G.L. and Schrieber L.  The influence of antigenic exposure on lymphocyte binding and high endothelial venule (HEV) morphology in germ free mice.  Presented at Annual Scientific Meeting of Australian Society for Immunology, Newcastle, December, 1986.
  29. Manolios N., Schrieber L and Geczy C.  The influence of anti-Ia on lymphocyte-high endothelial venule (HEV) interactions.  Presented at Annual Scientific Meeting of Australian Society for Immunology, Newcastle,  December, 1986.
  30. Manolios N., Schrieber L. and Geczy C.  Anti-Ia inhibits lymphocyte-high endothelial venule (HEV) interaction.  Arthritis Rheum.  30, S73, 1987.
  31. Schrieber L., Guiffre A.K. and Manolios N.  Aberrant lymphocyte trafficking profiles in systemic lupus erythematosus (SLE) mice are micro-environment independent.  Arthritis Rheum.  30, S122, 1987.
  32. Manolios N., Geczy C. and Schrieber L.  Augmented lymphocyte-high endothelial venule (HEV) binding in autoimmune mice.  Arthritis Rheum. 30, S122, 1987.
  33. Lal V., Schrieber L., Chivers T., Webb J. and Walker E. J.  Development of a sensitive and specific ELISA for the detection of anti-Jo-1 antibodies in patients with polymyositis and dermatomyositis.  Aust. NZ J Med. 18, 197, 1988.
  34. Schrieber L., McCredie M., Celermajer J. and Chivers T.  Congenital heart block (CHB), maternal connective tissue disease (CTD) and antibodies to SS- A/Ro.  Aust NZ J Med. 18, 198, 1988.
  35. Wang Y., Furphy L.,  Webb J., Pollard K.M., Schrieber L. and Cohen M.G.  Anticardiolipin antibodies in systemic lupus erythematosus.  Aust NZ J Med. 18, 200, 1988.
  36. Wang Y., Furphy L., Webb J., Cohen M.G., Schrieber L. and Pollard K.M.  Antiphospholipid antibodies in systemic lupus erythematosus.  Aust NZ J Med. 18, 200, 1988. 
  37. Garbett P.K., Jackson C.J., Brooks P.M. and Schrieber L.  Endothelial- fibroblast interaction in neovascularisation.  Aust NZ J Med. 18, 206, 1988.
  38. To S.S., Manolios N. and Schrieber L.  Effects of mitogen, cytokines and arachidonic acid metabolites on lymphocyte-endothelial interaction using a new in vitro centrifugation assay.  Aust NZ J Med. 18, 207, 1988.
  39. Manolios  N., Geczy C. and Schrieber L.  Anti-I-E does not influence lymphocyte-high endothelial venule (HEV) interaction.  Aust NZ J Med. 18, 207, 1988. 
  40. Manolios N., Geczy C. and Schrieber L.  Increased  -interferon (IFN) production in autoimmune mice (MRL/l, MRL/n) lymph nodes corresponds to disease onset.  Aust NZ J Med. 18, 208, 1988.
  41. Manolios N., Geczy C. and Schrieber L.  Gamma interferon ( IFN) augments high endothelial venule (HEV) binding of lymphocytes.  Aust NZ J Med. 18, 208, 1988. 
  42. Jackson C.J., Garbett P.K., Potter S.R., Sonnabend D.H. and Schrieber L.  Isolation and characterisation of cultured endothelium derived from adult rheumatoid synovium.  Aust NZ J Med. 18, 210, 1988.
  43. Schrieber L., McCredie M., Tugwell P. and Brooks P.M.  An evaluation of the role of laboratory investigations in establishing a diagnosis of central nervous system (CNS) lupus.  Aust NZ J Med. 18, 213, 1988.
  44. Manolios N., Geczy  C. and Schrieber L.  Gamma interferon (IFN) augments high endothelial venule (HEV) binding of lymphocytes.  Presented at Australian Societies for Experimental Biology Bicentennial Meeting, Canberra, February, 1988.
  45. Lal V., Schrieber L., Chivers T., Webb J. and Walker E.J.  Development of a sensitive and specific ELISA for the detection of anti-Jo-1 antibodies in patients with polymyositis and dermatomyositis.  Presented at Australian Societies for Experimental Biology Bicentennial Meeting, Canberra, February, 1988.
  46. Bakiera B., Manolios N., Schrieber L. and Geczy C.  Arachidonic acid (AA) metabolites do not influence lymphocyte-high endothelial venule (HEV) binding in autoimmune (MRL/n) and normal (CBA/T6) mice.  Presented at Combined Australian and New Zealand Rheumatism Association Meetings, Sydney, May, 1988.
  47. Schrieber L., McCredie M., Celermajer J.,  Sholler G., Kelly D., Chivers T. and Wang Y.  A case-control study of congenital heart block (CHB):  Association with maternal antibodies to La(SS-B).  Arthritis Rheum. 31:S66, 1988.
  48. Jackson C.J., Garbett P.K., Potter S.R., Sonnabend D.H. and Schrieber L.  Isolation and characterisation of cultured endothelium derived from adult rheumatoid synovium.  Arthritis Rheum. 31:S104, 1988.
  49. Jackson C.J., Garbett P.K., Marks R.M., Chapman G., Potter S.R., Sonnabend  D.H. and Schrieber L.  Isolation and propagation of endothelial cells derived from rheumatoid synovial vasculature.  Presented at Vth International Symposium on the Biology of the Vascular Endothelial Cell, Toronto, Canada, August, 1988.
  50. Barnes C., Bauman A., Brooks P., Donnelly H., Druce J., Dunsmore J., Phillips A., Rosendaal J. and Schrieber L. Development of an education programme for patients with systemic lupus erythematosus.  Presented at the Annual Scientific Meeting of the Australian Rheumatism Association, Melbourne, October, 1988.
  51. Jackson C.J., Nissen B., Garbett P.K. and Schrieber L.  An improved method of purifying human microvascular endothelium using ulex europaeus I coated dynabeads.   Presented at Annual Scientific Meeting of the Australian Society for Medical Research, Canberra, December, 1988.
  52. Schrieber L.  What's new in Rheumatoid Arthritis?   Presented at the Third National Conference of The Australian Jewish Medical Federation, Leura, January, 1989.
  53. Jackson C.J., Nissen B., Garbett P.K., Brooks P.M. and Schrieber L.  Isolation of endothelial cells (EC) from rheumatoid synovial vasculature using ulex europaeus I (UEA) coated dynabeads.   Presented at  7th International Congress of Immunology, Berlin, July, 1989.
  54. Chivers T., Laurent M.R., Gleeson R.J. and Schrieber L.   A comparison of nuclease treated and untreated 16C DNA in the Farr Assay.   Aust. NZ. J. Med. 20, 497, 1990.
  55. Jackson C.J., Garbett P.K., Brooks P.M. and Schrieber L.  The effect of soluble angiogenic agents and extracellular matrix proteins on the migration of microvascular endothelium.   Aust. NZ. J. Med. 20, 497, 1990.
  56. Schwarzer A.C., Arnold M.H., Preston S.J., Schrieber L. and Brooks P.M.  Combination chemotherapy in severe rheumatoid arthritis.   Aust. NZ. J. Med. 20, 498, 1990.
  57. Janssen B., Preston S.J., Tennant C., Roche., Reid W., Storey C. and Schrieber L.   Magnetic resonance imaging (MRI) and psychometric testing of neuropsychiatric (NP) lupus.   Aust. NZ. J. Med.  20, 508, 1990.
  58. Nethery A., Schrieber L., Brooks P.M., Ghosh P., Whitelock J. and O'Grady R.O.  Testing anti-rheumatic drugs as inhibitors of interstitial collagenase and other extracellular matrix metalloproteinases.  Presented at Pan-Pacific Connective Tissue Societies Symposium, Cairns, November, 1989.
  59. Janssen B., Tennant C., Roche J., Reid W., Storey C. and Schrieber L.  Magnetic resonance imaging (MRI) and psychometric testing of neuropsychiatric (NP) lupus.      Presented at Second International Conference on Systemic Lupus Erythematosus, Singapore, November, 1989.
  60. To S.S.T., Magoulas T. and Schrieber L.  Monoclonal antibodies against human umbilical vein endothelial cells stimulated by tumour necrosis factor -alpha.  Presented at Annual Scientific Meeting of Australian Society for Immunology, Adelaide, December, 1989.
  61. Nissen B., Garbett P.K. Jackson C.J., Brooks P.M. and Schrieber L.  Neovascularisation in vitro - the influence of endothelial cell population density on the rapid induction of tube formation by basement membrane gels.  Presented at National Scientific Conference of Australian Society for Medical Research, Adelaide, December, 1989.
  62. Gallery E.D.M., Jackson C.J. and Schrieber L. Purification of microvascular endothelium from human late pregnancy decidua.  Presented at Australasian Society for the study of hypertension in pregnancy, Melbourne, December, 1989.
  63. Gallery E.D.M., Jackson C.J. and Schrieber L.  Purification of microvascular endothelium from human late pregnancy decidua.  Presented at Annual Scientific Meeting of Australian Nephrological Society, Brisbane, March, 1990
  64. Schrieber L.   What's new in systemic lupus erythematosus?   Presented at the Fourth National Conference of the Australian Jewish Medical Federation, Alice Springs, July, 1990.
  65. Jackson C.J., Jenkins K., Garbett P.K., Brooks P.M. and Schrieber L.  The effect of soluble angiogenic agents and extracellular matrix proteins on  the replication and migration of microvascular endothelium.  Presented at the VIth International Symposium on the Biology of Vascular Cells, held in Paris, France, August, 1990.
  66. Lee M.L., Schrieber L., Cooper A. and Jones M.   Peripheral blood lymphocytes (PBL) from psoriatic patients demonstrate augmented binding to human umbilical vein endothelial cells (HUVE).   Presented at National Scientific Conference, Australian Society for Medical Research, Lorne, Victoria, December, 1990.
  67. Jenkins K., Schrieber L., Berndt M., Jackson C.   Action of   1 integrin receptor antibodies and protein kinase C inhibitors on cultured endothelium.   Presented at National Scientific Conference, Australian Society for Medical Research, Lorne, Victoria, December, 1990.
  68. Schrieber L.   Role of the endothelium in inflammation.   Presented at National Scientific Conference, Australian Society for Medical Research, Lorne, Victoria, December, 1990.
  69. Jackson C.J., Jenkins K. and Schrieber L.   Mechanisms of type 1 collagen induced vascular tube formation.   Presented at International Symposium on Angiogenesis, St. Gallen, Switzerland, March, 1991.
  70. Schrieber L.   The endothelium in rheumatoid arthritis.   Presented at 3rd Hall Institute Workshop on Rheumatic Diseases, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, March, 1991.
  71. Schrieber L.   The role of the endothelium in rheumatoid arthritis.  Presented at the 36th Annual Scientific Meeting of the Royal College of Pathologists of Australia, Melbourne, Victoria, October, 1991.
  72. Jackson C.J., Giles I., Nethery A. and Schrieber L.  Heparin, pentosan polysulphate and dextran sulphate trigger Type I collagen-induced vascular tube formation in vitro.   Presented at Annual Scientific Meeting of the Australian Rheumatology  Association, Perth, Western Australia, December, 1991.
  73. Nethery A., Giles I., Schrieber L., Brooks P.M., Burkhardt D., Ghosh P., O'Grady R.L. and Welgus A.G.   The chondroprotective drugs pentosan polysulphate and arteparon stimulate collagenase and inhibit stromyelsin activities in vitro.  Presented at Annual Scientific Meeting of the Australian Rheumatology Association, Perth, Western Australia, December, 1991.
  74. Giles I., Nethery A., Schrieber L. and Jackson C.J.   The angiogenic capacity of sulphated glycosaminoglycans.    Presented at The National Scientific Conference of the Australian Society for Medical Research, Canberra, A.C.T., December, 1991.
  75. Savvas P, Janssen B, Preston S, Roche J, Reid W, Caine D, Storey C, Tennant C and Schrieber L.  Prospective study of magnetic resonance imaging (MRI) and psychometric testing in neuropsychiatric (NP) lupus.  Presented at Third International Conference on Systemic Lupus Erythematosus, London, England, April 1992.
  76. Brooks P.M., Edmonds J.P., March L. and Schrieber L.   Undergraduate teaching in musculoskeletal medicine.   Presented at National Scientific Conference of the Australian Rheumatology Association, Sydney, May, 1992.
  77. Savvas P., Janssen B., Preston S., Roche J., Reid W., Caine D., Storey C., Tennant C. and Schrieber L.   Prospective study of magnetic resonance imaging (MRI) and psychometric testing in neuropsychiatric (NP) lupus.   Presented at National Scientific Conference of the Australian Rheumatology Association, Sydney, May, 1992.
  78. Lee M.L., Schrieber L., Cooper A. and Jones M.  Peripheral blood lymphocytes (PBL) from psoriatic patients demonstrate increased binding to human umbilical vein endothelial cells (HUVE).  Presented at 18th World Congress of Dermatology, New York, USA, June, 1992.
  79. Barnes C., Dunsmore J., Schrieber L., Brooks P. and Priestley D.   Development of a patient education programme for people with systemic lupus erythematosus.   Presented at IVth International Symposium for Health Professionals in Rheumatology, Harrowgate, United Kingdom, June, 1992.
  80. Jackson C.J., Giles I., Nethery A. and Schrieber L.   Highly sulphated polysaccharides stimulate cultured endothelial cells to form vascular tubes in response to type I collagen.   Presented at VIIth International Symposium on the Biology of Vascular Cells, San Diego, November, 1992.
  81. Lowe P.M., Jackson C., Giles I., LeGuay J. and Schrieber L.  Angiogenic activity of psoriatic sera in vitro.   Presented at National Scientific Conference of the Australian Society for Medical Research, Brisbane, December, 1992
  82. Jackson C., Giles I., Berndt M. and Schrieber L.  Antibodies to the  2 1 integrin receptor inhibit Type I collagen-induced vascular tube formation.   Presented at 2nd Baker Institute Symposium, "Current Concepts in Vascular Biology", Melbourne, December, 1992.
  83. Gallery E.D.M., Rowe J., Fry A, Jackson C.J., Schrieber L., Magoulas T., Penny R. and Danis V.   Production of vasoactive substances by cultured microvascular endothelial cells from human decidual tissue in late pregnancy.   Presented at Second Baker Institute Symposium on "Current Concepts in Vascular Biology", Melbourne, December, 1992.
  84. To S.S.T., Newman P. and Schrieber L.   Increased intercellular adhesion molecule I(ICAM-1) expression by human synovial microvascular endothelial cells.   J. Cell Biochem. 17A, S336, 1993.
  85. Gallery EDM, Fry A, Rowe J, Jackson C, Schrieber L, Magoulas ST and Penny R.   Production of vasoactive substances by human late pregnancy decidual capillary endothelial cells.  Presented at the Annual Scientific Meeting of the Australian Society for Nephrology, Hobart, March, 1993.
  86. Newman P., To S.S.T. and Schrieber L.   Vascular cell adhesion molecule -1(VCAM-1) expression on endothelial cells is inhibited by gold sodium thiomalate (GST).  Presented at XVIIIth ILAR Congress of Rheumatology, Barcelona, Spain, July, 1993.
  87. Savvas P., Janssen B, Preston S., Roche J., Reid W., Caine D., Storey C., Tennant C. and Schrieber L.   Magnetic resonance imaging (MRI) and psychometric testing in neuropsychiatric (NP) lupus.   Presented at  XVIIIth ILAR Congress of Rheumatology, Barcelona, Spain, July, 1993.
  88. Lowe P.M., Jackson C.J., Giles I., LeGuay J. and Schrieber L.   Psoriatic sera stimulate the proliferation and migration of cultured human endothelial cells.   Presented at Annual Scientific Meeting of the Australasian College of Dermatologists, Melbourne, May, 1993.
  89. Lowe P.M., Jackson C.J., Giles I., LeGuay J. and Schrieber L.   Psoriatic sera stimulate the proliferation and migration of cultured human endothelial cells.   Presented at Dermatology 2000 Conference, Vienna, Austria, May, 1993.   
  90. Newman P, To SST and Schrieber L.   Gold sodium thiomalate inhibits vascular cell adhesion molecule -1 expression on  endothelial cells.  Presented at Annual Scientific Conference of the Australian Rheumatology Association, Adelaide, May, 1993.
  91. To SST, Newman P, Jackson C and Schrieber L.   Adhesion molecule expression by human synovial microvascular endothelial cells. Presented at First Scientific Meeting of the Australian Vascular Biology Society, Sunshine Coast, Queensland, August, 1993.
  92. Schrieber L, Newman P, Robinson BG, Hyland V and To SST.   The role of endothelial adhesion molecules in inflammation.  Presented at First Asian Congress for Microcirculation, Osaka, Japan, September, 1993.
  93. Jackson CJ, Knop A, Giles I, Gallery EDM and Schrieber L.   Collagenase secretion by human microvascular endothelial cells derived from neonatal foreskin deciduum and rheumatoid arthritis synovium. Presented at National Scientific Conference, Australian Society for Medical Research, Adelaide, November, 1993.
  94. Jackson CJ Knop A and Schrieber L.  Collagenase secretion of human microvascular endothelial cells derived from neonatal foreskin and rheumatoid arthritic synovium.  Presented at Annual Scientific Conference, Australian Rheumatology Association, Melbourne, May, 1994.
  95. To SST, Newman PM, Hyland VJ, Robinson BG and Schrieber L.  Construction of a cDNA library from rheumatoid synovial microvascular endothelial cells.  Presented at 4th Australian Rheumatoid Arthritis Symposium, Melbourne, May, 1994.
  96. Jackson C, Knop A, Nguyen M and Schrieber L.  Collagenase secretion by human endothelial cells derived from rheumatoid arthritis synovium, neonatal foreskin and human umbilical vein.  Presented at VIIIth International Symposium on the Biology Vascular Cells, Heidelberg, Germany, August, 1994.
  97. Newman PM, To SST, Robinson BG, Hyland VJ and Schrieber L.  Effect of gold sodium-thiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules.  Presented at the Annual Scientific Meeting of the American College of Rheumatology, Minneapolis, USA, October, 1994.
  98. Jackson CJ, Nguyen M and Schrieber L.  Type IV collagenase secretion by human microvascular endothelial cells is bipolar dependent.  Presented at Second Scientific Meeting of the Australian Vascular Biology Society, Adelaide, November, 1994.
  99. Schrieber L.  Management of scleroderma.  Presented at Annual Scientific Conference of the Australian Society for Clinical Immunology and Allergy, Canberra, December, 1994.
  100. To SST, Newman PM, Hyland VJ, Robinson BG and Schrieber L.  Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro.  Presented at Annual Scientific Meeting of the Australian Rheumatology Association, Auckland, NZ, May, 1995.
  101. Jackson C, Nguyen M and Schrieber L.  Matrix metalloproteinase (MMP) secretion by rheumatoid arthritic synovial microvascular endothelial cells (RASE).  Presented at Annual Scientific Meeting of the Australian Rheumatology Association, Auckland, NZ, May, 1995.
  102. Shen J, Devery J M, To T, Schrieber L and King NJC.  Early direct induction of E‑Selectin, VCAM‑1 and ICAM‑1 expression on HUVEC by flavivirus infection.  Presented at 34th National Scientific Conference of the Australian Society for Medical Research, Leura, NSW, November 1995.
  103. Schrieber, L, Newman P M, Hyland V J, Robinson B G and To SST.  Adhesion molecule expression by human synovial microvascular endothelium. Presented at Eighth Asian Pacific League Against Rheumatism (APLAR) Congress, Melbourne, April, 1996.
  104. Danis VA and Schrieber L. Polymorphisms in cytokine genes (IL-1 and TNF-a) in relation to rheumatoid arthritis.  Presented at Eighth Asian Pacific League Against Rheumatism (APLAR) Congress, Melbourne, April 1996.
  105. Bannister MJ,  Jackson CJ, Nguyen QM, Cooper AJ and Schrieber L.  Isolation and characterisation of microvascular endothelium derived from human psoriatic plaques.  Presented at National Scientific Conference of the Australian Society for Medical Research, Gold Coast, Queensland, November 1996.
  106. Bannister M.J., Jackson C.J., Nguyen Q.M., Cooper A.J. and Schrieber L.  Isolation and characterisation of microvascular endothelium derived from human psoriatic plaques.  Presented at Ninth Australian and New Zealand Symposium on the Microcirculation, Melbourne, February 1997.
  107. Dorai-Raj A., Makowey J., Podgorski M., Needs C., Schrieber L., March L., Laurent R, Sambrook P.  Effects of corticosteroid use and disease activity on bone assessed by quantitative ultrasound in patients with rheumatoid arthritis.  Presented to Annual Scientific Meeting of the New South Wales Branch of the Australian Rheumatology Association, Port Stephens, N.S.W., November, 1997.
  108. Schrieber L., Hendry G. and Bryce D.  Patient Partners in arthritis education - a pilot study - are they better teachers than rheumatologists?  Presneted at Annual Scientific Meeting of the New South Wales Branch of the Australian Rheumatology Association, Port Stephens, N.S.W., November, 1997.
  109. Schrieber L., Hendry G., Bryce D. and Curran R.  Presented at Faculty of Medicine, University of Sydney Curriculum Conference 97, Wollongong, November, 1997.
  110. Schrieber L.  New approaches in the treatment of rheumatoid arthritis.  Presented at Eighth        National Conference of the Australasian Jewish Medical Federation to Alpha Omega International Dental Fraternity, Adelaide, January, 1998.
  111. Gibbons K, Koch A, Robinson B and Schrieber L. Differentially expressed synovial endothelial  genes in chronic inflammatory arthritis. Presented at Annual Scientific Meeting of the Australian Rheumatology Association, Sydney, May, 1998.
  112. Schrieber L, Hendry G and Bryce D. Patient partners in arthritis education- a pilot study. Presented at the Annual Scientific Meeting of the Australian Rheumatology Asssociation, Sydney, May 1998.
  113. Schrieber L, Hendry G and Bryce D. Patient partners in arthritis education - a pilot study. Presented at the 62nd National Scientific Conference of the American College of Rheumatology , San Diego, November 1998.
  114. Dorai-Raj A, Hunter D, Makowey J, Podgorski M, Needs C, Schrieber L, March L, Laurent R and Sambrook P. Effects of corticosteroid use and disease activity on bone assessed by quantitative ultrasound in patients with rheumatoid arthritis. Presented at 62nd National Scientific Conference of the American College of Rheumatology, San Diego, November 1998.
  115. Hunter D, Schrieber L, Laurent R, March L and Sambrook P. Assessment of rheumatological education of final year medical undergraduate students. Presented at Annual Scientific Meeting of the NSW Branch of the Australian Rheumatology Association, Leura, NSW, November 1998.
  116. Schrieber L, Hendry G and Hunter D. Patient partners in the teaching of graduate medical program students. Presented at the Annual Scientific Meeting of the Australian Rheumatology Association, Perth, May 1999.
  117. Schrieber L, Hendry G and Hunter D. Patient partners in the teaching of grraduate medical program students. Presented at the 63rd National Scientific Conference of the American College of Rheumatology, Boston, November 1999.
  118. Schrieber L, Hendry GD and Hunter D. Patient partners in the teaching of graduate medical  program students. Presented at Biennial Curricululum Conference, Faculty of Medicine, University of Sydney, December 1999.
  119. Fu A, Laurent R, Needs C, Arnold M, Schrieber L and Sambrook P. Effect of intravenous Pamidronate on bone mineral density in the treatment of osteoporosis. Presented at Annual Scientific Meeting of NSW Branch of the Australian Rheumatology Association, Hunter Valley, NSW, November 2001.
  120. Schrieber L. COX-2 Specific inhibitors –are they safer? Presented at the 10th Biennial Conference of the Australasian Jewish Medical Federation, Maroochydore, Queensland, January 2002.
  121. Schrieber L. USydMP-The Graduate Medical Program of The University of Sydney –An Exciting New Experiment, Presented at 30 Year Medical Reunion Conference, Faculty of Medicine, University of Sydney, Hunter Valley, October 2002.
  122. Schrieber L. Rheumatoid Arthritis- The era of biological therapy has dawned. Presented at the 11th Biennial Scientific Conference of the Australasian Jewish Medical Federation, Maroochydore, Queensland, January 2004.
  123. Englert H, Moore J, Anandacoomarasamy A, Austin S, Bak H, KatelarisC, McGill N, Schrieber L and Manolios N  Autologous stem cell transplantation for early diffuse systemic scleroderma; the Australian experience. Presented at the 47th Annual Scientfic Meeting of the Australian Rheumatology Assocation, Melbourne, May 2005
  124. Sharpe L, Curran L, Chauhan D, Levy J, Denton F and Schrieber L. A randomized controlled trial of cognitive, behavioural or cognitive-behavioural treatment for patients with rheumatoid arthritis( RA). Presented at the 35th European Asociation of Cognitive and Behavioural Therapies, Athens Greece September 2005.
  125. Schrieber L. The changing face of lupus. Presented at the 12th Biennial Scientific Conference of the Australasian Jewish Medical Federation, Dunborough, Western Australia, January 2006
  126. O’Neill SG, Giles I Schrieber L March L Isenberg DA and Rahman A. Antibodies to apolipoprotein A1 are associated with persistent disease activity in patients with systemic lupus erythematosus. Presented at the 50th Annual Scientfic Meeting of the Australian Rheumatology Assocation, Adelaide, May 2008
  127. O’Neill SG Woldman S Isenberg DA Schrieber L March L Taylor A and Rahman A. Could cardiac magnetic resonance imaging have a role in the management of systemic lupus erythematosus? Presented at the 50th Annual Scientfic Meeting of the Australian Rheumatology Assocation, Adelaide, May 2008
  128. O’Neill SG, Schrieber L, March L, Isenberg DA and Rahman A. Use of cardiovascular risk scores in patients with SLE. Presented at the Annual Scientific Meeting of NSW Branch of the Australian Rheumatology Association, Bowral, NSW, November 2008.
  129. Cheung P Dervish S Xue M Schrieber L March L and Jackson C. Dose Protein C/ Activated Protein C play a role in the inflammatory pathway of rheumatoid arthritis? Presented at the Annual Scientific Meeting of NSW Branch of the Australian Rheumatology Association, Bowral, NSW, November 2008
  130. Englert H Moore J Poon T Austin S Bak H Janssen B Katelaris C McGill N Ma D Schrieber L Manolios N Longterm follow up of autologous stem cell transplantation for diffuse scleroderma Int Med J 39(suppl) A 38, 2009
  131. Proudman SM, Byron J, Zochling J, Youssef PP, Nash PT, Tymms K, Chan MT, Sturgess A, Schrieber L, Hill CL, Celermajer DS, Sahhar JM  and StevensWM. An on-line screening tool for cardiopulmonary complications of scleroderma- the Australian Scleroderma Screening Program, presented at the Annual Scientific Meeting of the American College of Rheumatology, Philadelphia October 2009
  132. Schrieber L and Richards B. The changing face of scleroderma. Presented at the 15th Biennial National Conference of the Australasian Jewish Medical Federation, Coolum, Queensland January 2010.
  133. Stevens W, Byron J, Roddy J, Hill C, Major G, Nash P, Sahhar J, SchrieberL, Sturgess A, Tymms C, Zochling J, Youssef P, Nikpour M and Proudman S at 12th Annual Congress of  EULAR, London May 2011.
  134. Stevens W, Nikpour M, Byron J. Roddy J, Zochling, Sahhar J, . Nash, P. Youssef P, Tymms K,Sturgess A, . Major G, and. Proudman S. Frequency, clinical characteristics and risk factors for digital ulcers in systemic sclerosis.EULAR (European League Against Rheumatism) annual congress, London May 2011. Ann Rheum Dis 2011;70 (Suppl3):669.
  135. Nikpour M, Proudman S, Byron J, Zochling J, Roddy J, Sahhar J, Nash P, Youssef P, Tymms K, Sturgess A, Major G, Hill C, Schrieber L, Stevens W. Mortality and causes of death in an Australian systemic sclerosis cohort. ARA-RPHA Annual Scientific Meeting, Brisbane May 2011.Internal Medicine Journal 2011:41 (Suppl 1); p 12.
  136. Ngian G, Sahhar J, Byron J, Proudman S, Hill C, Roddy J, Youssef P, Tymms K, Schrieber L, Wendy S, Zochling J, Nash P, Sturgess A, Major G, Wicks I, Van Doornum S. Prevalence of coronary heart disease in a cohort of Australian scleroderma patients.  ARA-RPHA Annual Scientific Meeting, Brisbane May 2011.Internal Medicine Journal 2011:41 (Suppl 1); p 11.
  137. Schrieber L. COXIBs- Are they really safe? Presented at the 16th Biennial National Conference of the Australasian Jewish Medical Federation, Coffs Harbour, NSW, January 2012.
  138. Stevens W, Thakkar V, Moore O, J Byron J, Proudman S, Zochling J, Roddy J, Sahhar J, Nash      P, Youssef P, Major G, Tymms K, Hill C, Sturgess A, Schrieber L and Nikpour M. Lung disease is the major cause of death in the Australian Systemic Sclerosis Cohort study. 2nd Systemic Sclerosis World Congress, Madrid, Spain, February,2012. Clinical and Experimental Rheumatology (Scleroderma Care and Research) 2012
  139. Schrieber L. Coxibs- are they really safe? Presented at the 7th Annual Scientific Meeting of The Society of Neuromuscular Sciences, Niseko, Japan January 2013
  140. Schrieber L. Treatment of rheumatoid arthritis (RA) in the biological era. Presented at the 8th Annual Scientific Meeting of The Society of Neuromuscular Sciences, Niseko, Japan January 2014.
  141. Schrieber L Lupus-An Improving Prognosis. Presented athe 9th Annual Scientific Meeting of The Society of Neuromuscular Sciences, Niseko, Japan January 2015.

 

Autoimmune Journal Flyer